Clinical Trial Manager at Medpace
Lyon Area, France
Country Manager France @ Overall management of the CRO in France and proper conduct of the studies. Served as Lead CRA on a project for 2 years. From May 2005 to Present (10 years 8 months) Country Manager @ From 2005 to Present (10 years) CRA @ CRA involved in start-up activities, sites set up and monitoring...
Country Manager France @ Overall management of the CRO in France and proper conduct of the studies. Served as Lead CRA on a project for 2 years. From May 2005 to Present (10 years 8 months) Country Manager @ From 2005 to Present (10 years) CRA @ CRA involved in start-up activities, sites set up and monitoring on over 20 clinical trials, phase II to IV, local and international in various therapeutic areas. From 1998 to 2005 (7 years) CRA @ From 1998 to 1998 (less than a year) MBA, Management of Pharmaceutical Industry @ IAE FRANCE - Écoles Universitaires de Management From 1996 to 1997 Master, Molecular and cellular biology @ Ecole normale supérieure de Lyon From 1994 to 1996 Master, Biology @ Université Claude Bernard Lyon 1 From 1991 to 1996 Patrick Winkler is skilled in: CRO, Clinical Trials, Therapeutic Areas, GCP, Clinical Operations, Oncology, CTMS, Cardiology, Clinical Monitoring, Clinical Development, Pharmacovigilance, Infectious Diseases, Endocrinology, EDC, Lifesciences
Overall management of the CRO in France and proper conduct of the studies. Served as Lead CRA on a project for 2 years. Overall management of the CRO in France and proper conduct of the studies. Served as Lead CRA on a project for 2 years.
What company does Patrick Winkler work for?
Patrick Winkler works for Medpace Europe
What is Patrick Winkler's role at Medpace Europe?
Patrick Winkler is Country Manager France
What industry does Patrick Winkler work in?
Patrick Winkler works in the industry.
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies